Factors influencing residual nodal burden in patients with node positive breast cancer treated with neoadjuvant chemotherapy with residual node positive disease enrolled on Alliance A011202 clinical trial


- Citation:
- Meeting Instance:
- SABCS 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None